Public interest biomedical technologies challenge the market-driven model of innovation by asking a different question: who benefits, and how broadly? This perspective highlights the gap between what markets prioritize (profit) and what society needs (health impact).

The Commons emphasizes developing technologies for underserved populations and neglected diseases, treating foundational scientific knowledge as a shared commons rather than private property, ensuring that publicly funded research delivers public benefit, and designing medical innovations with access and affordability as core principles rather than afterthoughts.